190 Results

People

  1. Saltz
    Saltz
  2. Kelsen
    Kelsen
  3. Bajorin
    Bajorin
  4. O'Reilly
    O'Reilly
  5. Abrey
    Abrey
  6. Marks
    Marks
  7. Aghajanian
    Aghajanian
  8. Ilson
    Ilson
  9. De Angelis
    De Angelis
  10. Kelly
    Kelly

Groups

  1. Department of Medicine (143)
  2. Solid Tumor Oncology Division (115)
  3. Gastrointestinal Oncology Service (39)
  4. Epidemiology and Biostatistics (31)
  5. Biostatistics Service (29)
  6. Center for Pancreatic Cancer Research (29)
  7. Hematologic Malignancies, Division of (29)
  8. Survivorship Research (27)
  9. Genitourinary Oncology Service (25)
  10. Surgery (25)
  1. "dehydration"
Formats
  1. Journal Article (185)
  2. Review (2)
  3. Book Section (1)
  4. Conference Paper (1)
  5. Editorial (1)
Groups
  1. Department of Medicine (143)
  2. Solid Tumor Oncology Division (115)
  3. Gastrointestinal Oncology Service (39)
  4. Epidemiology and Biostatistics (31)
  5. Biostatistics Service (29)
  6. Center for Pancreatic Cancer Research (29)

More Groups

People
  1. Leonard Saltz (12)
  2. David Kelsen (10)
  3. Dean Bajorin (9)
  4. Eileen O'Reilly (9)
  5. Lauren Abrey (8)
  6. Paul Marks (8)

More People

Years
  1. 2025 (1)
  2. 2024 (11)
  3. 2023 (7)
  4. 2022 (2)
  5. 2021 (6)
  6. 2020 (11)

More Years

Publications
  1. Cancer (17)
  2. Journal of Clinical Oncology (16)
  3. Lancet Oncology (14)
  4. Gynecologic Oncology (10)
  5. Investigational New Drugs (10)
  6. Clinical Cancer Research (9)

More Publications

Publishers
  1. Elsevier Inc. (31)
  2. Springer (21)
  3. Wiley Blackwell (20)
  4. American Society of Clinical Oncology (16)
  5. Elsevier Science, Inc. (16)
  6. Oxford University Press (16)

More Publishers

Results (190)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Randomized phase II trial of sunitinib on an intermittent versus continuous dosing schedule as first-line therapy for advanced renal cell carcinoma
    Journal Article

    Motzer, R. J.; Hutson, T. E.; Olsen, M. R.; Hudes, G. R.; Burke, J. M. ; Edenfield, W. J.; Wilding, G.; Agarwal, N.; Thompson, J. A.; Cella, D.; more...
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save
  • Active comparator-controlled, rater-blinded study of corticotropin-based immunotherapies for opsoclonus-myoclonus syndrome
    Journal Article

    Tate, E. D.; Pranzatelli, M. R.; Verhulst, S. J.; Markwell, S. J.; Franz, D. N.; Graf, W. D.; Joseph, S. A.; Khakoo, Y. N.; Lo, W. D.; Mitchell, W. G.; more...
    Journal of Child Neurology (2012)

    Fulltext@MSK | Save
  • Phase III trial of cetuximab, bevacizumab, and 5-fluorouracil/leucovorin vs. FOLFOX-bevacizumab in colorectal cancer
    Journal Article

    Saltz, L.; Badarinath, S.; Dakhil, S.; Bienvenu, B.; Harker, W. G.; Birchfield, G.; Tokaz, L. K.; Barrera, D.; Conkling, P. R.; O'Rourke, M. A.; more...
    Clinical Colorectal Cancer (2012)

    Fulltext@MSK | Save
  • Afatinib versus placebo for patients with advanced, metastatic non-small-cell lung cancer after failure of erlotinib, gefitinib, or both, and one or two lines of chemotherapy (LUX-Lung 1): A phase 2b/3 randomised trial
    Journal Article

    Miller, V. A.; Hirsh, V.; Cadranel, J.; Chen, Y. M.; Park, K.; Kim, S. W.; Zhou, C.; Su, W. C.; Wang, M.; Sun, Y.; more...
    Lancet Oncology (2012)

    Fulltext@MSK | Save
  • Ipilimumab in patients with melanoma and brain metastases: An open-label, phase 2 trial
    Journal Article

    Margolin, K.; Ernstoff, M. S.; Hamid, O.; Lawrence, D.; McDermott, D.; Puzanov, I.; Wolchok, J. D.; Clark, J. I.; Sznol, M.; Logan, T. F.; more...
    Lancet Oncology (2012)

    Fulltext@MSK | Save
  • The efficacy and safety of panitumumab administered concomitantly with FOLFIRI or irinotecan in second-line therapy for metastatic colorectal cancer: The secondary analysis from STEPP (skin toxicity evaluation protocol with panitumumab) by KRAS status
    Journal Article

    Mitchell, E. P.; Piperdi, B.; Lacouture, M. E.; Shearer, H.; Iannotti, N.; Pillai, M. V.; Xu, F.; Yassine, M.
    Clinical Colorectal Cancer (2011)

    Fulltext@MSK | Save
  • Pralatrexate with vitamin supplementation in patients with previously treated, advanced non-small cell lung cancer: Safety and efficacy in a phase 1 trial
    Journal Article

    Azzoli, C. G.; Patel, J. D.; Krug, L. M.; Miller, V.; James, L.; Kris, M. G.; Ginsberg, M.; Subzwari, S.; Tyson, L.; Dunne, M.; more...
    Journal of Thoracic Oncology (2011)

    Fulltext@MSK | Save
  • Phase I study of two schedules of oral S-1 in combination with fixed doses of oxaliplatin and bevacizumab in patients with advanced solid tumors
    Journal Article

    Chung, K. Y.; Saito, K.; Zergebel, C.; Hollywood, E.; Segal, M.; Saltz, L. B.
    Oncology (2011)

    Fulltext@MSK | Save
  • Colon cancer: Clinical practice guidelines in oncology
    Journal Article

    Benson, A. B. 3rd; Arnoletti, J. P.; Bekaii-Saab, T.; Chan, E.; Chen, Y. J.; Choti, M. A.; Cooper, H. S.; Dilawari, R. A.; Engstrom, P. F.; Enzinger, P. C.; more...
    Journal of the National Comprehensive Cancer Network (2011)

    Fulltext@MSK | Save
  • Recent Advances in the treatment of breast cancer: Highlights from the 2010 San Antonio Breast Cancer Symposium - Management of Advanced Breast Cancer
    Journal Article

    Hudis, C.
    Clinical Advances in Hematology & Oncology (2011)

    Fulltext@MSK | Save